Cleara Biotech Secures U.S. and Chinese Patent Protection for its p53-Targeting Development Candidate CL04183

Toxys and Mutagentech Expand Access to Next-Generation Mutation Analysis Through Strategic Collaboration

MAASH secures over €12 million to accelerate its next phase of growth

Revier Therapeutics Launches with €6 Million Seed Financing to Pioneer Class IIa HDAC Inhibitors for Cardiometabolic Disease

BioMarin to Acquire Alesta Therapeutics for Up to $490 Million, Advancing Oral Treatment for Rare Bone Disease Hypophosphatasia

Novo Nordisk and AWS Enter Strategic Partnership to Transform Drug Discovery with AI

Curium acquirs Abscint SA, expanding PET radiodiagnostic pipeline in oncology

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

National investment agenda aims to position the Netherlands as a global leader in industrial biotechnology